BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Henkel J, Frede K, Schanze N, Vogel H, Schürmann A, Spruss A, Bergheim I, Püschel GP. Stimulation of fat accumulation in hepatocytes by PGE2-dependent repression of hepatic lipolysis, β-oxidation and VLDL-synthesis. Lab Invest. 2012;92:1597-1606. [PMID: 22964849 DOI: 10.1038/labinvest.2012.128] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Petri BJ, Piell KM, Wahlang B, Head KZ, Andreeva K, Rouchka EC, Cave MC, Klinge CM. Polychlorinated biphenyls alter hepatic m6A mRNA methylation in a mouse model of environmental liver disease. Environ Res 2023;216:114686. [PMID: 36341798 DOI: 10.1016/j.envres.2022.114686] [Reference Citation Analysis]
2 Ishizawa S, Nishi A, Kaifuchi N, Shimobori C, Nahata M, Yamada C, Iizuka S, Ohbuchi K, Nishiyama M, Fujitsuka N, Kono T, Yamamoto M. Integrated analysis of effect of daisaikoto, a traditional Japanese medicine, on the metabolome and gut microbiome in a mouse model of nonalcoholic fatty liver disease. Gene 2022;846:146856. [PMID: 36067864 DOI: 10.1016/j.gene.2022.146856] [Reference Citation Analysis]
3 Civelek E, Ozen G. The biological actions of prostanoids in adipose tissue in physiological and pathophysiological conditions. Prostaglandins Leukot Essent Fatty Acids 2022;186:102508. [PMID: 36270150 DOI: 10.1016/j.plefa.2022.102508] [Reference Citation Analysis]
4 Maciejewska-Markiewicz D, Drozd A, Palma J, Ryterska K, Hawryłkowicz V, Załęska P, Wunsh E, Kozłowska-Petriczko K, Stachowska E. Fatty Acids and Eicosanoids Change during High-Fiber Diet in NAFLD Patients-Randomized Control Trials (RCT). Nutrients 2022;14:4310. [PMID: 36296994 DOI: 10.3390/nu14204310] [Reference Citation Analysis]
5 Fekry B, Ribas-Latre A, Drunen RV, Santos RB, Shivshankar S, Dai Y, Zhao Z, Yoo SH, Chen Z, Sun K, Sladek FM, Younes M, Eckel-Mahan K. Hepatic circadian and differentiation factors control liver susceptibility for fatty liver disease and tumorigenesis. FASEB J 2022;36:e22482. [PMID: 35947136 DOI: 10.1096/fj.202101398R] [Reference Citation Analysis]
6 Yin H, Shi A, Wu J. Platelet-Activating Factor Promotes the Development of Non-Alcoholic Fatty Liver Disease. Diabetes Metab Syndr Obes 2022;15:2003-30. [PMID: 35837578 DOI: 10.2147/DMSO.S367483] [Reference Citation Analysis]
7 Tian J, Du Y, Yu E, Lei C, Xia Y, Jiang P, Li H, Zhang K, Li Z, Gong W, Xie J, Wang G. Prostaglandin 2α Promotes Autophagy and Mitochondrial Energy Production in Fish Hepatocytes. Cells 2022;11:1870. [PMID: 35740999 DOI: 10.3390/cells11121870] [Reference Citation Analysis]
8 Callegari IOM, Oliveira AG. The Role of LTB4 in Obesity-Induced Insulin Resistance Development: An Overview. Front Endocrinol 2022;13:848006. [DOI: 10.3389/fendo.2022.848006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ayyash A, Holloway AC. Fluoxetine-induced hepatic lipid accumulation is mediated by prostaglandin endoperoxide synthase 1 and is linked to elevated 15-deoxy-Δ12,14 PGJ2. J Appl Toxicol 2021. [PMID: 34897744 DOI: 10.1002/jat.4272] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Camacho-Muñoz D, Kiezel-Tsugunova M, Kiss O, Uddin M, Sundén M, Ryaboshapkina M, Lind L, Oscarsson J, Nicolaou A. Omega-3 carboxylic acids and fenofibrate differentially alter plasma lipid mediators in patients with non-alcoholic fatty liver disease. FASEB J 2021;35:e21976. [PMID: 34618982 DOI: 10.1096/fj.202100380RRR] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Wang W, Zhong X, Guo J. Role of 2‑series prostaglandins in the pathogenesis of type 2 diabetes mellitus and non‑alcoholic fatty liver disease (Review). Int J Mol Med 2021;47:114. [PMID: 33907839 DOI: 10.3892/ijmm.2021.4947] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
12 Xu D, Cai J, Wan ZK, Gao H, Sun Y. Pathophysiological role of prostaglandin E synthases in liver diseases. Prostaglandins Other Lipid Mediat 2021;154:106552. [PMID: 33930567 DOI: 10.1016/j.prostaglandins.2021.106552] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Aliabadi F, Ajami M, Pazoki–toroudi H. Why does COVID‐19 pathology have several clinical forms? BioEssays 2020;42:2000198. [DOI: 10.1002/bies.202000198] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
14 Wu J, Wang Y, Zhou Y, Wang Y, Sun X, Zhao Y, Guan Y, Zhang Y, Wang W. PPARγ as an E3 Ubiquitin-Ligase Impedes Phosphate-Stat6 Stability and Promotes Prostaglandins E2-Mediated Inhibition of IgE Production in Asthma. Front Immunol 2020;11:1224. [PMID: 32636842 DOI: 10.3389/fimmu.2020.01224] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Desmarais F, Bergeron K, Ntambi JM, Rassart E, Mounier C. Fatty acid mediators and the inflammasome. Lipid Signaling and Metabolism 2020. [DOI: 10.1016/b978-0-12-819404-1.00011-7] [Reference Citation Analysis]
16 Henkel J, Coleman CD, Schraplau A, Jöhrens K, Weiss TS, Jonas W, Schürmann A, Püschel GP. Augmented liver inflammation in a microsomal prostaglandin E synthase 1 (mPGES-1)-deficient diet-induced mouse NASH model. Sci Rep 2018;8:16127. [PMID: 30382148 DOI: 10.1038/s41598-018-34633-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
17 Vasconcelos ACCG, Vasconcelos DFP, Pereira da Silva FR, de Carvalho França LF, Alves EHP, Lenardo DD, dos Santos Pessoa L, Novaes PD, Luiz dos Reis Barbosa A, Mani A, Mariano FS, Medeiros JR, de Oliveira AP. Periodontitis causes abnormalities in the liver of rats. J Periodontol 2019;90:295-305. [DOI: 10.1002/jper.18-0226] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
18 Pierre C, Guillebaud F, Airault C, Baril N, Barbouche R, Save E, Gaigé S, Bariohay B, Dallaporta M, Troadec JD. Invalidation of Microsomal Prostaglandin E Synthase-1 (mPGES-1) Reduces Diet-Induced Low-Grade Inflammation and Adiposity. Front Physiol 2018;9:1358. [PMID: 30333759 DOI: 10.3389/fphys.2018.01358] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
19 Shen L, Xie TR, Yang RZ, Chen Y, Kang JS. Application of a dye-based mitochondrion-thermometry to determine the receptor downstream of prostaglandin E2 involved in the regulation of hepatocyte metabolism. Sci Rep 2018;8:13065. [PMID: 30166566 DOI: 10.1038/s41598-018-31356-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
20 Musso G, Cassader M, Paschetta E, Gambino R. Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis. Gastroenterology 2018;155:282-302.e8. [PMID: 29906416 DOI: 10.1053/j.gastro.2018.06.031] [Cited by in Crossref: 148] [Cited by in F6Publishing: 149] [Article Influence: 29.6] [Reference Citation Analysis]
21 Musso G, Gambino R, Cassader M, Paschetta E, Sircana A. Specialized Proresolving Mediators: Enhancing Nonalcoholic Steatohepatitis and Fibrosis Resolution. Trends in Pharmacological Sciences 2018;39:387-401. [DOI: 10.1016/j.tips.2018.01.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
22 de Castro GS, Calder PC. Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids. Clinical Nutrition 2018;37:37-55. [DOI: 10.1016/j.clnu.2017.01.006] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 13.4] [Reference Citation Analysis]
23 Araújo AC, Wheelock CE, Haeggström JZ. The Eicosanoids, Redox-Regulated Lipid Mediators in Immunometabolic Disorders. Antioxid Redox Signal 2018;29:275-96. [PMID: 28978222 DOI: 10.1089/ars.2017.7332] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
24 Martín-Sanz P, Casado M, Boscá L. Cyclooxygenase 2 in liver dysfunction and carcinogenesis: Facts and perspectives. World J Gastroenterol 2017; 23(20): 3572-3580 [PMID: 28611510 DOI: 10.3748/wjg.v23.i20.3572] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
25 Reccia I, Kumar J, Akladios C, Virdis F, Pai M, Habib N, Spalding D. Non-alcoholic fatty liver disease: A sign of systemic disease. Metabolism. 2017;72:94-108. [PMID: 28641788 DOI: 10.1016/j.metabol.2017.04.011] [Cited by in Crossref: 102] [Cited by in F6Publishing: 104] [Article Influence: 17.0] [Reference Citation Analysis]
26 Henkel J, Coleman CD, Schraplau A, Jӧhrens K, Weber D, Castro JP, Hugo M, Schulz TJ, Krämer S, Schürmann A, Püschel GP. Induction of steatohepatitis (NASH) with insulin resistance in wildtype B6 mice by a western-type diet containing soybean oil and cholesterol. Mol Med 2017;23:70-82. [PMID: 28332698 DOI: 10.2119/molmed.2016.00203] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 5.5] [Reference Citation Analysis]
27 Tian J, Lei C, Ji H, Jin A. Role of cyclooxygenase-mediated metabolites in lipid metabolism and expression of some immune-related genes in juvenile grass carp (Ctenopharyngodon idellus) fed arachidonic acid. Fish Physiol Biochem 2017;43:703-17. [DOI: 10.1007/s10695-016-0326-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
28 Tian J, Lei C, Ji H, Chen L, Du Z. Dietary Arachidonic Acid Has a Time-Dependent Differential Impact on Adipogenesis Modulated via COX and LOX Pathways in Grass Carp Ctenopharyngodon idellus. Lipids 2016;51:1325-38. [DOI: 10.1007/s11745-016-4205-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
29 Abruzzese GA, Heber MF, Ferreira SR, Velez LM, Reynoso R, Pignataro OP, Motta AB. Prenatal hyperandrogenism induces alterations that affect liver lipid metabolism. J Endocrinol 2016;230:67-79. [PMID: 27179108 DOI: 10.1530/JOE-15-0471] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
30 Manowsky J, Camargo RG, Kipp AP, Henkel J, Püschel GP. Insulin-induced cytokine production in macrophages causes insulin resistance in hepatocytes. Am J Physiol Endocrinol Metab 2016;310:E938-46. [PMID: 27094035 DOI: 10.1152/ajpendo.00427.2015] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
31 Nobili V, Alisi A, Musso G, Scorletti E, Calder PC, Byrne CD. Omega-3 fatty acids: Mechanisms of benefit and therapeutic effects in pediatric and adult NAFLD. Crit Rev Clin Lab Sci. 2016;53:106-120. [PMID: 26463349 DOI: 10.3109/10408363.2015.1092106] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
32 Nasrallah R, Hassouneh R, Hébert RL. PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes. J Am Soc Nephrol 2016;27:666-76. [PMID: 26319242 DOI: 10.1681/ASN.2015050528] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 5.6] [Reference Citation Analysis]
33 Nakano T. Roles of lipid-modulating enzymes diacylglycerol kinase and cyclooxygenase under pathophysiological conditions. Anat Sci Int 2015;90:22-32. [PMID: 25471593 DOI: 10.1007/s12565-014-0265-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
34 Lappas M. NOD1 expression is increased in the adipose tissue of women with gestational diabetes. Journal of Endocrinology 2014;222:99-112. [DOI: 10.1530/joe-14-0179] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
35 Lotowska JM, Sobaniec-Lotowska ME, Bockowska SB, Lebensztejn DM. Pediatric non-alcoholic steatohepatitis: The first report on the ultrastructure of hepatocyte mitochondria. World J Gastroenterol 2014; 20(15): 4335-4340 [PMID: 24764670 DOI: 10.3748/wjg.v20.i15.4335] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
36 Hesse D, Radloff K, Jaschke A, Lagerpusch M, Chung B, Tailleux A, Staels B, Schürmann A. Hepatic trans-Golgi action coordinated by the GTPase ARFRP1 is crucial for lipoprotein lipidation and assembly. J Lipid Res 2014;55:41-52. [PMID: 24186947 DOI: 10.1194/jlr.M040089] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
37 Brenner C, Galluzzi L, Kepp O, Kroemer G. Decoding cell death signals in liver inflammation. J Hepatol 2013;59:583-94. [PMID: 23567086 DOI: 10.1016/j.jhep.2013.03.033] [Cited by in Crossref: 562] [Cited by in F6Publishing: 573] [Article Influence: 56.2] [Reference Citation Analysis]
38 He Y, Gong L, Fang Y, Zhan Q, Liu HX, Lu Y, Guo GL, Lehman-McKeeman L, Fang J, Wan YJ. The role of retinoic acid in hepatic lipid homeostasis defined by genomic binding and transcriptome profiling. BMC Genomics 2013;14:575. [PMID: 23981290 DOI: 10.1186/1471-2164-14-575] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
39 vinh quốc Lu'o'ng K, Nguyễn LT. The beneficial role of vitamin D in obesity: possible genetic and cell signaling mechanisms. Nutr J 2013;12:89. [PMID: 23800102 DOI: 10.1186/1475-2891-12-89] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
40 Basaranoglu M, Basaranoglu G, Sabuncu T, Sentürk H. Fructose as a key player in the development of fatty liver disease. World J Gastroenterol 2013; 19(8): 1166-1172 [PMID: 23482247 DOI: 10.3748/wjg.v19.i8.1166] [Cited by in CrossRef: 151] [Cited by in F6Publishing: 158] [Article Influence: 15.1] [Reference Citation Analysis]